0001654954-20-002623.txt : 20200313 0001654954-20-002623.hdr.sgml : 20200313 20200313164450 ACCESSION NUMBER: 0001654954-20-002623 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200313 DATE AS OF CHANGE: 20200313 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Beyond Air, Inc. CENTRAL INDEX KEY: 0001641631 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 473812456 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-90353 FILM NUMBER: 20713412 BUSINESS ADDRESS: STREET 1: 825 EAST GATE BOULEVARD, SUITE 320 CITY: GARDEN CITY STATE: NY ZIP: 11530 BUSINESS PHONE: 516-665-8200 MAIL ADDRESS: STREET 1: 825 EAST GATE BOULEVARD, SUITE 320 CITY: GARDEN CITY STATE: NY ZIP: 11530 FORMER COMPANY: FORMER CONFORMED NAME: AIT Therapeutics, Inc. DATE OF NAME CHANGE: 20170117 FORMER COMPANY: FORMER CONFORMED NAME: KokiCare, Inc. DATE OF NAME CHANGE: 20150507 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Mosseri Marlio Charles CENTRAL INDEX KEY: 0001806384 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: 27 RIPPLEVALE GROVE CITY: LONDON STATE: X0 ZIP: N1 1HS SC 13G 1 mossei-13g.htm PRIMARY DOCUMENT template_sc13g.htm
 
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G
 
Under the Securities Exchange Act of 1934
 
 
Beyond Air, Inc.
 
 
(Name of Issuer)
 
 
 
 
 
Common Stock, par value $0.0001 per share
 
 
(Title of Class of Securities)
 
 
 
 
 
08862L03
 
 
(CUSIP Number)
 
 
 
 
 
March 9, 2020
 
 
(Date of Event Which Requires Filing of this Statement)
 
 
 
 
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed
 

Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
 
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 
 
 
1
 

1.
Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
 
Charles Mosseri Marlio
2.
Check the Appropriate Box if a Member of a Group (See Instructions)
 
(a) 
(b) 
3.
SEC Use Only
 
4.
Citizenship of Place of Organization
 
France
Number of Shares
Beneficially
Owned by Each
Reporting  Person
With
5.
Sole Voting Power 
 
1,415,396
6.
Shared Voting Power
 0
7. 
Sole Dispositive Power 
 
1,415,396
8.
Shared Dispositive Power
 
0
9.
Aggregate Amount Beneficially Owned by each Reporting Person
 
1,415,396
10.
Check if the Aggregate Amount in Row (9) Excludes Certain Shares  ☐
 
11.
Percent of Class Represented by Amount in Row 9
 
9.8%*
12.
Type of Reporting Person (See Instructions)
 
IN
 
*Calculated based on 14,384,014 shares outstanding as provided by the Issuer in its latest Form 10-Q filed February 7, 2020.
 
 
2
 
 
Item l(a)
Name of Issuer:
 
Beyond Air, Inc.
 
Iteml (b).
Address of Issuer's Principal Executive Offices:
 
825 East Gate Blvd., Suite 320
Garden City, NY 11530
 
Item2 (a) & (b).
Name and Principal Business Offices of Persons Filing:
 
Charles Mosseri Marlio
c/o Charles Russell Speechlys AG
Basteiplatz 7
8001 Zurich

 
Item 2(c).
Citizenship:
 
              
France
 
Item2 (d).
Title of Class of Securities:
 
              
Common Stock, par value $0.0001 per share
 
Item 2(e).
CUSIP Number:
 
08862L103
 
Item 3.
If this statement is filed pursuant to §§240.13d–1(b) or 240.13d–2(b) or (c), check whether the person filing is a:
 
(a) [ ] Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
 
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
 
(c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
 
(d) [ ] Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a–8).
 
(e) [ ] An investment adviser in accordance with §240.13d–1(b)(1)(ii)(E);
 
(f) [ ] An employee benefit plan or endowment fund in accordance with §240.13d–1(b)(1)(ii)(F);
 
(g) [ ] A parent holding company or control person in accordance with §240.13d–1(b)(1)(ii)(G);
 
(h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
 
(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a–3);
 
(j) [ ] Group, in accordance with §240.13d–1(b)(1)(ii)(J).
 
 
 
3
 
 
Item 4.
Ownership.
 
(a)
Amount beneficially owned:
 
1,415,396
 
(b)
Percent of Class
 
9.8%*
 
(c)
Number of shares as to which such person has
 
  
(i)
sole power to vote or to direct the vote:
 
1,415,396
 
(ii)
shared power to vote or to direct the vote:
 
0
 
(iii)
sole power to dispose or to direct the disposition of:
 
1,415,396
 
(iv)
shared power to dispose or to direct the disposition of:
 
0
 
5.
Ownership of Five Percent or Less of a Class.
 
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ].
 
6.
Ownership of More than Five Percent on Behalf of Another Person.
 
Not Applicable
 
7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
 
N/A
 
8.
Identification and Classification of Members of the Group.
 
N/A
 
9.
Notice of Dissolution of Group.
 
N/A
 
* Calculated based on 14,384,014 shares outstanding as provided by the Issuer in its latest Form 10-Q filed February 7, 2020.
 
10.
Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 
 
4
 
 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
 
 
 
 
 
 
March 13, 2020
By:
/s/ Charles Mosseri Marlio
 
Date:
  Name:  
Charles Mosseri Marlio
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5